MAPT and Alzheimer disease: Mechanistic understanding is also incomplete, as illustrated by the role of the glymphatic system in AD; while validated in animals, human verification is hindered by the lack of noninvasive detection tools, and its causal relationship with Aβ/tau accumulation remains unconfirmed [253].